Publications

Transactions

To read this full article you need to be subscribed to Newsline.

Start Your Free Trial Now View Purchase Options

HCN to sell stake in life science portfolio for $573.5m

by Andrea Waitrovich

Health Care REIT has agreed to sell its 49 percent interest in seven life science buildings located at Massachusetts Institute of Technology’s University Park, a mixed-use life science campus, in Cambridge, Mass.  

The buyer is Forest City Enterprises, which will purchase HCN’s interest for $573.5 million, including HCN’s pro rata share of property-level debt of $174 million. The purchase price represents a projected 5 percent cap rate based on forward 12 months net operating income.

The two companies entered into a 51-49 equity joint venture for the properties in February 2010. At that time, HCN invested $327 million, including assumed debt, for its 49 percent interest.

The sale of the life science portfolio is incremental to HCN’s most recently disclosed 2015 disposition guidance of $400 million and is expected to be completed during the second half of 2015.

In February, HCN sold a 10-property portfolio to Venta

Glossary, videos, podcasts, research in the Resource Center

Forgot your username or password?